These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21418221)

  • 21. Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Shi J; Qin X; Chang X; Wang H; Guo J; Zhang W
    J Cell Mol Med; 2022 Jan; 26(2):583-587. PubMed ID: 34866307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofilaments in pre-symptomatic ALS and the impact of genotype.
    Benatar M; Wuu J; Lombardi V; Jeromin A; Bowser R; Andersen PM; Malaspina A
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Nov; 20(7-8):538-548. PubMed ID: 31432691
    [No Abstract]   [Full Text] [Related]  

  • 23. Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS.
    Oeckl P; Jardel C; Salachas F; Lamari F; Andersen PM; Bowser R; de Carvalho M; Costa J; van Damme P; Gray E; Grosskreutz J; Hernández-Barral M; Herukka SK; Huss A; Jeromin A; Kirby J; Kuzma-Kozakiewicz M; Amador Mdel M; Mora JS; Morelli C; Muckova P; Petri S; Poesen K; Rhode H; Rikardsson AK; Robberecht W; Rodríguez Mahillo AI; Shaw P; Silani V; Steinacker P; Turner MR; Tüzün E; Yetimler B; Ludolph AC; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):404-13. PubMed ID: 27415180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis.
    Gendron TF; ; Daughrity LM; Heckman MG; Diehl NN; Wuu J; Miller TM; Pastor P; Trojanowski JQ; Grossman M; Berry JD; Hu WT; Ratti A; Benatar M; Silani V; Glass JD; Floeter MK; Jeromin A; Boylan KB; Petrucelli L
    Ann Neurol; 2017 Jul; 82(1):139-146. PubMed ID: 28628244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.
    Lu CH; Macdonald-Wallis C; Gray E; Pearce N; Petzold A; Norgren N; Giovannoni G; Fratta P; Sidle K; Fish M; Orrell R; Howard R; Talbot K; Greensmith L; Kuhle J; Turner MR; Malaspina A
    Neurology; 2015 Jun; 84(22):2247-57. PubMed ID: 25934855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis.
    Gonçalves M; Tillack L; de Carvalho M; Pinto S; Conradt HS; Costa J
    Clin Chim Acta; 2015 Jan; 438():342-9. PubMed ID: 25261856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.
    Wang XK; Zhang HL; Meng FH; Chang M; Wang YZ; Jin T; Mix E; Zhu J
    Neurol Sci; 2013 May; 34(5):655-61. PubMed ID: 22526766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS.
    Halbgebauer S; Steinacker P; Verde F; Weishaupt J; Oeckl P; von Arnim C; Dorst J; Feneberg E; Mayer B; Rosenbohm A; Silani V; Ludolph AC; Otto M
    J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):68-74. PubMed ID: 34417339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated levels of phosphorylated neurofilament heavy subunit in the cerebrospinal fluid of patients with lumbar spinal stenosis: preliminary findings.
    Ohya J; Chikuda H; Kato S; Hayakawa K; Oka H; Takeshita K; Tanaka S; Ogata T
    Spine J; 2015 Jul; 15(7):1587-92. PubMed ID: 25797810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis.
    Weydt P; Oeckl P; Huss A; Müller K; Volk AE; Kuhle J; Knehr A; Andersen PM; Prudlo J; Steinacker P; Weishaupt JH; Ludolph AC; Otto M
    Ann Neurol; 2016 Jan; 79(1):152-8. PubMed ID: 26528863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylated neurofilament heavy chain: a potential diagnostic biomarker in amyotrophic lateral sclerosis.
    Heckler I; Venkataraman I
    J Neurophysiol; 2022 Mar; 127(3):737-745. PubMed ID: 35138963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromogranin A levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Verde F; Steinacker P; Oeckl P; Weishaupt JH; Rosenbohm A; Silani V; Ludolph AC; Otto M
    Neurobiol Aging; 2018 Jul; 67():21-22. PubMed ID: 29609078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.
    Kaiserova M; Grambalova Z; Otruba P; Stejskal D; Prikrylova Vranova H; Mares J; Mensikova K; Kanovsky P
    Acta Neurol Scand; 2017 Oct; 136(4):360-364. PubMed ID: 28185258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients.
    Steinacker P; Feneberg E; Weishaupt J; Brettschneider J; Tumani H; Andersen PM; von Arnim CA; Böhm S; Kassubek J; Kubisch C; Lulé D; Müller HP; Muche R; Pinkhardt E; Oeckl P; Rosenbohm A; Anderl-Straub S; Volk AE; Weydt P; Ludolph AC; Otto M
    J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):12-20. PubMed ID: 26296871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.
    Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M
    Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum neurofilament heavy chains as early marker of motor neuron degeneration.
    De Schaepdryver M; Goossens J; De Meyer S; Jeromin A; Masrori P; Brix B; Claeys KG; Schaeverbeke J; Adamczuk K; Vandenberghe R; Van Damme P; Poesen K
    Ann Clin Transl Neurol; 2019 Oct; 6(10):1971-1979. PubMed ID: 31518073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics.
    Behzadi A; Pujol-Calderón F; Tjust AE; Wuolikainen A; Höglund K; Forsberg K; Portelius E; Blennow K; Zetterberg H; Andersen PM
    Sci Rep; 2021 Nov; 11(1):22128. PubMed ID: 34764380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis.
    Lehnert S; Costa J; de Carvalho M; Kirby J; Kuzma-Kozakiewicz M; Morelli C; Robberecht W; Shaw P; Silani V; Steinacker P; Tumani H; Van Damme P; Ludolph A; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):344-50. PubMed ID: 24575871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF markers in amyotrophic lateral sclerosis.
    Tarasiuk J; Kułakowska A; Drozdowski W; Kornhuber J; Lewczuk P
    J Neural Transm (Vienna); 2012 Jul; 119(7):747-57. PubMed ID: 22555610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of neurofilaments in differentiating motor neuron disease from multifocal motor neuropathy.
    Wohnrade C; Seeliger T; Gingele S; Bjelica B; Skripuletz T; Petri S
    J Neurol; 2024 Jul; 271(7):4441-4452. PubMed ID: 38683209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.